Reliability of sentinel node procedure for lymph node staging in prostate cancer patients at high risk for lymph node involvement

References

• Hovels AM, Heesakkers RA, Adang EM, Jager GJ, Strum S, Hoogeveen YL, et al. The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: A meta-analysis. Clin Radiol 2008;63: 387–95.
   PubMed Web of Science ®Google Scholar
• Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, et al. EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and treatment of clinically localised disease. Eur Urol 2011;59:61–71.
   PubMed Web of Science ®Google Scholar
• Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127: 392–9.
   PubMed Web of Science ®Google Scholar
• Sadeghi R, Tabasi KT, Bazaz SM, Kakhki VR, Massoom AF, Gholami H, et al. Sentinel node mapping in the prostate cancer. Meta-analysis. Nuklearmedizin 2011;50:107–15.
   PubMedGoogle Scholar
• Briganti A, Chun FK, Salonia A, Suardi N, Gallina A, Da Pozzo LF, et al. Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol 2006;50: 1006–13.
   PubMed Web of Science ®Google Scholar
• Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 2001;58:843–8.
   PubMed Web of Science ®Google Scholar
• Budiharto T, Joniau S, Lerut E, Van den Bergh L, Mottaghy F, Deroose CM, et al. Prospective evaluation of 11C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases. Eur Urol 2011;60:125–30.
   PubMed Web of Science ®Google Scholar
• Beri A, Janetschek G. Technology insight: Radioguided sentinel lymph node dissection in the staging of prostate cancer. Nat Clin Pract Urol 2006;3:602–10.
   PubMedGoogle Scholar
• Hsu C-Y, Joniau S, Van Poppel H. Radical prostatectomy for locally advanced prostate cancer: Technical aspects of radical prostatectomy. EAU Update Series 2005;90–7.
   Google Scholar
• Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002;20:3628–36.
   PubMed Web of Science ®Google Scholar
• Samaratunga H, Montironi R, True L, Epstein JI, Griffiths DF, Humphrey PA, et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling. Mod Pathol 2011;24: 6–15.
   PubMed Web of Science ®Google Scholar
• Greene DR, Wheeler TM, Egawa S, Dunn JK, Scardino PT. A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. J Urol 1991;146:1069–76.
   PubMed Web of Science ®Google Scholar
• Winter A, Vogt C, Weckermann D, Wawroschek F. [Complications of pelvic lymphadenectomy in clinically localised prostate cancer: Different techniques in comparison and dependency on the number of removed lymph nodes]. Aktuelle Urol 2011;42:179–83.
   PubMed Web of Science ®Google Scholar
• Vermeeren L, Valdes Olmos RA, Meinhardt W, Bex A, van der Poel HG, Vogel WV, et al. Value of SPECT/CT for detection and anatomic localization of sentinel lymph nodes before laparoscopic sentinel node lymphadenectomy in prostate carcinoma. J Nucl Med 2009;50:865–70.
   PubMed Web of Science ®Google Scholar
• Ganswindt U, Schilling D, Muller AC, Bares R, Bartenstein P, Belka C. Distribution of prostate sentinel nodes: A SPECT-derived anatomic atlas. Int J Radiat Oncol Biol Phys 2011; 79:1364–72.
   PubMed Web of Science ®Google Scholar
• Mattei A, Fuechsel FG, Bhatta DN, Warncke SH, Thalmann GN, Krause T, et al. The template of the primary lymphatic landing sites of the prostate should be revisited: Results of a multimodality mapping study. Eur Urol 2008; 53:118–25.
   PubMed Web of Science ®Google Scholar
• Holl G, Dorn R, Wengenmair H, Weckermann D, Sciuk J. Validation of sentinel lymph node dissection in prostate cancer: experience in more than 2,000 patients. Eur J Nucl Med Mol Imaging 2009;36:1377–82.
   PubMed Web of Science ®Google Scholar
• Lyman GH, Giuliano AE, Somerfield MR, Benson AB, III, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005; 23:7703–20.
   PubMed Web of Science ®Google Scholar
• Rousseau C, Rousseau T, Bridji B, Pallardy A, Lacoste J, Campion L, et al. Laparoscopic sentinel lymph node (SLN) versus extensive pelvic dissection for clinically localized prostate carcinoma. Eur J Nucl Med Mol Imaging 2012; 39:291–9.
   PubMed Web of Science ®Google Scholar
• Weckermann D, Dorn R, Holl G, Wagner T, Harzmann R. Limitations of radioguided surgery in high-risk prostate cancer. Eur Urol 2007;51:1549–56.
   PubMed Web of Science ®Google Scholar
• Brenot-Rossi I, Rossi D, Esterni B, Brunelle S, Chuto G, Bastide C. Radioguided sentinel lymph node dissection in patients with localised prostate carcinoma: Influence of the dose of radiolabelled colloid to avoid failure of the procedure. Eur J Nucl Med Mol Imaging 2008;35:32–8.
   PubMed Web of Science ®Google Scholar
• Buckle T, Brouwer OR, Valdes Olmos RA, van der Poel HG, van Leeuwen FW. Relationship between intraprostatic tracer deposits and sentinel lymph node mapping in prostate cancer patients. J Nucl Med 2012;53:1026–33.
   PubMed Web of Science ®Google Scholar
• Isebaert S, Haustermans K, Van den Bergh L, Joniau S, Dirix P, Oyen R, et al. Identification and characterization of nodal metastases in prostate cancer patients at high risk for lymph node involvement. Acta Oncol 2013;52:1336–44.
   PubMed Web of Science ®Google Scholar
• Joniau S, Van den Bergh L, Peeters C, Haustermans K, Spahn M. Nodal staging in prostate cancer: Still an unresolved issue. Eur Urol 2012;61:1139–41.
   PubMed Web of Science ®Google Scholar
• Malmstrom PU. Lymph node staging in prostatic carcinoma revisited. Acta Oncol 2005;44:593–8.
   PubMed Web of Science ®Google Scholar
• Verhagen PC, Schroder FH, Collette L, Bangma CH. Does local treatment of the prostate in advanced and/or lymph node metastatic disease improve efficacy of androgen-deprivation therapy? A systematic review. Eur Urol 2010; 58:261–9.
   Google Scholar
• Abdollah F, Karnes RJ, Suardi N, Cozzarini C, Gandaglia G, Fossati N, et al. Impact of adjuvant radiotherapy on survival of patients with node-positive prostate cancer. J Clin Oncol Epub 2014 Sep 22.
   Google Scholar
• Briganti A, Karnes RJ, Da Pozzo LF, Cozzarini C, Capitanio U, Gallina A, et al. Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: Results of a matched analysis. Eur Urol 2011;59:832–40.
   PubMed Web of Science ®Google Scholar
• Briganti A, Suardi N, Capogrosso P, Passoni N, Freschi M, di Trapani E, et al. Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum. Prostate 2012;72:186–92.
   PubMed Web of Science ®Google Scholar
• Joniau S, Van den Bergh L, Lerut E, Deroose CM, Haustermans K, Oyen R, et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol 2013;63:450–8.
   PubMed Web of Science ®Google Scholar
• Meinhardt W, van der Poel HG, Valdes Olmos RA, Bex A, Brouwer OR, Horenblas S. Laparoscopic sentinel lymph node biopsy for prostate cancer: The relevance of locations outside the extended dissection area. Prostate Cancer 2012;2012:751753.
   PubMedGoogle Scholar